Arch Biopartners Inc (ARCH.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2 | 2 | 2 | 12 | 0 |
| Receivables | 0 | 182 | 241 | 309 | 737 |
| Inventories | 0 | 196 | 181 | 163 | 44 |
| Other current assets | 0 | 77 | 67 | 0 | 0 |
| TOTAL | $2 | $552 | $526 | $504 | $837 |
| Non-Current Assets | |||||
| PPE Net | 0 | 147 | 181 | 118 | 140 |
| Other Non-Current Assets | 0 | 99 | 254 | 332 | 181 |
| TOTAL | $0 | $245 | $434 | $450 | $320 |
| Total Assets | $2 | $797 | $960 | $953 | $1,157 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,643 | 1,353 | 940 | 1,057 |
| Accounts payable and accrued liabilities | N/A | N/A | 501 | 361 | 615 |
| Other current liabilities | N/A | 182 | 120 | 297 | 371 |
| TOTAL | $348 | $2,572 | $1,974 | $1,598 | $2,043 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $N/A | $N/A | $2 |
| Total Liabilities | $348 | $2,572 | $1,974 | $1,598 | $2,045 |
| Shareholders' Equity | |||||
| Common Shares | 13,269 | 861 | 0 | 0 | 0 |
| Retained earnings | -14,473 | -3,324 | -2,666 | -2,305 | -2,287 |
| Other shareholders' equity | 0 | -170 | 22 | 30 | 90 |
| TOTAL | $-346 | $-1,775 | $-1,013 | $-644 | $-887 |
| Total Liabilities And Equity | $2 | $797 | $960 | $953 | $1,157 |